In cancer cells, EIF4A3 is associated with posttranscriptional modification, cell cycle progression, and acceleration of cell growth (Han et al., 2016; Mazloomian et al., 2019; Zheng et al., 2020). The gene discussed is EIF4A3; the disease is cancer.